DDD Partners’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
Other funds holding ARKG
DDD Partners's ARKG Position: Q3 2026 in Review
DDD Partners reduced its ARK Genomic Revolution ETF (ARKG) stake by 5.2% in Q3 2026, selling an estimated $38.2K and leaving 15,334 shares worth $831K. The position accounts for 0.05% of the portfolio, ranked #104.
DDD Partners first reported a position in ARKG in Q2 2022 and has held it in 18 quarters since. The position peaked at $6.19M in Q2 2023. 153 funds tracked by Wall St. Rank hold ARKG as of Q3 2026.
- DDD Partners held 15,334 shares of ARK Genomic Revolution ETF worth $831K as of Q3 2026.
- DDD Partners sold 849 ARK Genomic Revolution ETF shares in Q3 2026, an estimated $38.2K.
- ARK Genomic Revolution ETF made up 0.05% of DDD Partners's portfolio in Q3 2026, its #104 holding.
- DDD Partners first reported a position in ARK Genomic Revolution ETF in Q2 2022 and has held it in 18 quarters since.
- DDD Partners's ARK Genomic Revolution ETF position peaked at $6.19M in Q2 2023.
- 153 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q3 2026.
Based on DDD Partners's 13F filing for Q3 2026, filed 2 Nov 2026.